Home › NDC Lookup › Ingredients › Cd73, Cd90, Cd105, Icam-1, Hgf › 87622-0003-01
CPC Chondrocyte Preparation CD73, CD90, CD105, ICAM-1, HGF 5'-NUCLEOTIDASE .9 mg/mL; 1 .7 mg/mL; .9 mg/mL; .9 mg/mL; .5 mg/mL Suspension — NDC 87622-0003-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

CPC Chondrocyte Preparation CD73, CD90, CD105, ICAM-1, HGF 5'-NUCLEOTIDASE .9 mg/mL; 1 .7 mg/mL; .9 mg/mL; .9 mg/mL; .5 mg/mL Suspension — NDC 87622-003-01 (Billing 87622-0003-01)

by Zhongke Zhongluan Biotechnology (Guangdong) Co., Ltd. · 1 VIAL in 1 BOX / 3 mL in 1 VIAL

This is a package of CPC Chondrocyte Preparation CD73, CD90, CD105, ICAM-1, HGF 5'-NUCLEOTIDASE .9 mg/mL; 1 .7 mg/mL; .9 mg/mL; .9 mg/mL; .5 mg/mL Suspension from Zhongke Zhongluan Biotechnology (Guangdong) Co., Ltd., marketed since Jul 2026 and currently FDA-listed. It is this product's only package size.

NDC 87622-0003-01
🏷️ FDA NDC (as labeled) 87622-003-01 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Aug 27, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 87622-003-01 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
87622 labeler · 003 product · 01 package
Package marketed since
Jul 14, 2026
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Barcode (UPC-A, from the NDC)
3 8762200301 6
FDA record last changed
Aug 27, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 87622-003-01
Product NDC 87622-003
11-digit billing NDC 87622000301
UNII T8635M4C7O, 602I13CWRT, 1Y8Q34P575, EAD36Y912K, BEI7G52Q8Z
SPL Set ID 568c5aff-b978-0d9e-e063-6294a90a3de4
DEA schedule Non-controlled
Marketing category UNAPPROVED DRUG OTHER
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2026-07-14
Route TOPICAL
Dosage form SUSPENSION
Substance 5'-NUCLEOTIDASE; INTERCELLULAR ADHESION MOLECULE 1; ENDOGLIN; THY-1 MEMBRANE GLYCOPROTEIN; HUMAN HEPATOCYTE GROWTH FACTOR
Why two NDCs? The FDA registers this code as 87622-003-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 87622-0003-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

This is an unapproved topical suspension containing five active components derived from chondrocytes and growth factors. The preparation includes 5'-nucleotidase, adhesion molecules (CD73, CD90, CD105, ICAM-1), and human hepatocyte growth factor (HGF). These components are typically found in products intended to support cellular communication and tissue repair processes. This product is marketed without FDA approval.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
87622-0003-01 You're viewing this Main listing 1 VIAL in 1 BOX / 3 mL in 1 VIAL 2026-07-14 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
CPC Chondrocyte Preparation 5'-NUCLEOTIDASE .9 mg/mL; 1 .7 mg/mL; .9 mg/mL; .9 mg/mL; .5 mg/mLthis 87622-0003-01 Zhongke 1 vial — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2026
On the market since
Jul 2026
📍
2026
Currently FDA-listed
listed with the FDA
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 451W47IQ8X
    Sodium chloride is common table salt. It's used in medicines as a buffer to maintain proper pH, as a filler to add bulk, or to adjust the osmotic balance in liquid formulations.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

2 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesSodium chloride, Water

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerZhongke Zhongluan Biotechnology (Guangdong) Co., Ltd.
Labeler code87622
First marketedJul 2026
Product typeHuman Otc Drug
Portfolio3 products on file

More NDCs from Zhongke Zhongluan Biotechnology (Guangdong) Co.,... labeler code 87622

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 Ask a Doctor or Pharmacist Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 18 words ▾

Use For topical / local external use; apply only to the target local area according to labeling directions.

⏱️ Dosage and Administration 35 words ▾

Directions Mix gently before use. Each vial contains 3 mL; apply topically to the target skin / local area in a thin layer until absorbed; use once daily; use as a single-use vial after opening.

⚠️ Warnings 182 words ▾

Warnings For topical / local external use only; do not ingest, inject, or apply to eyes, mucous membranes, or broken skin; single use only. Ask a doctor before use if you have active skin infection, open wounds, severe skin disease, known allergy to protein-based ingredients, or are pregnant or breastfeeding. Ask a doctor or pharmacist before use if you are using other topical medicines, anti-allergy medicines, or immune-related treatments.

Do not use if the package is damaged or leaking; the storage temperature has deviated from the required range; the suspension appears abnormally turbid, discolored, or contains visible foreign matter; the product has been frozen or repeatedly frozen and thawed; or the labeled expiration date has passed. Stop use and ask a doctor if rash, redness, swelling, itching, irritation, hypersensitivity, or any other discomfort occurs. When using this product avoid contact with eyes, mucous membranes, and broken skin; avoid vigorous shaking; do not freeze or refreeze; use immediately after opening as a single-use vial.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 30 words ▾

Other information Specification: 3 mL/vial; Dosage form: Suspension; Route of administration: Topical / local external use; store refrigerated at 2–8°C; do not freeze; use as a single-use vial after opening.

🧪 Active Ingredient 17 words ▾

Active Ingredient CD73: 0.90 mg/mL CD90: 0.90 mg/mL CD105: 0.90 mg/mL ICAM-1: 0.70 mg/mL HGF: 0.50 mg/mL

🧪 Inactive Ingredients 5 words ▾

Inactive ingredients Sodium chloride, Water

🎯 Purpose 10 words ▾

Purpose Active protein-factor suspension for topical / local external use

📄 Do Not Use 47 words ▾

Do not use if the package is damaged or leaking; the storage temperature has deviated from the required range; the suspension appears abnormally turbid, discolored, or contains visible foreign matter; the product has been frozen or repeatedly frozen and thawed; or the labeled expiration date has passed.

📄 Ask a Doctor Before Use If 26 words ▾

Ask a doctor before use if you have active skin infection, open wounds, severe skin disease, known allergy to protein-based ingredients, or are pregnant or breastfeeding.

📄 Ask a Doctor or Pharmacist Before Use If 19 words ▾

Ask a doctor or pharmacist before use if you are using other topical medicines, anti-allergy medicines, or immune-related treatments.

📄 When Using This Product 29 words ▾

When using this product avoid contact with eyes, mucous membranes, and broken skin; avoid vigorous shaking; do not freeze or refreeze; use immediately after opening as a single-use vial.

📄 Stop Use and Ask a Doctor If 18 words ▾

Stop use and ask a doctor if rash, redness, swelling, itching, irritation, hypersensitivity, or any other discomfort occurs.

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Package Label / Principal Display Panel 2 words ▾

PACK 3ML

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Over-the-counter (OTC) product Marketed without an FDA application

Listed without an FDA application

This product's marketing category indicates it is marketed without an approved FDA application (no NDA, ANDA, or BLA on file). Having an NDC does not by itself establish FDA approval — the NDC Directory is a listing system, not an approval decision. Approval-linked data such as Orange Book therapeutic-equivalence ratings therefore does not apply.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Drug Other". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Zhongke Zhongluan Biotechnology (Guangdong) Co., Ltd.. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Zhongke Zhongluan Biotechnology (Guangdong) Co., Ltd. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 87622-0002-01 · Zhongke 87623-0001-01 · Epic →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.